FDA gives pre-market clearance to Cerner fetal surveillance solution; NexTech Native iPad EMR app granted several patents;

> Cerner's FetaLink+, a solution that provides clinicians access to maternal and fetal surveillance information via an iPad or iPhone, recently received 510(k) pre-market clearance from the U.S. Food and Drug Administration. The mobile fetal monitoring solution allows clinicians to assess the status of patients by displaying the relationship of fetal and maternal waveforms, allowing clinicians to more easily analyze changes in waveform patterns over time. Announcement

> The U.S. Patent and Trademark Office has issued patents to NexTech for its Native iPad EMR application, protecting the design from reproduction and use of products with a similar design. The NexTech EMR iPad app harnesses the power of an electronic chart, combined with a design inspired by the paper chart, allowing users to document patient visits the way they are accustomed. Announcement

> Indianapolis-based Healthx has announced plans for the launch of mHealth Manager in early 2013. Built upon Healthx's secure HIPAA-compliant platform, the turnkey solution is designed for Payers to better engage members in their disease management by utilizing market-leading mHealth apps and devices. Announcement

And Finally... Want to rent out the Popemobile for your bachelor party? Now you can. Article

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.